Directors' Dealings

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen (pta025/03.08.2020/11:45) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Prof. Dr. Hermann Lübbert
2 Reason for the notification
a) Position/status Executive
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Another
Granting of 99,425 subscription rights in connection with the issue of a qualified subordinated mandatory convertible bond
c) Price(s) Volume(s)
0.00 EUR 0.00 EUR
d) Aggregated price Aggregated volume
0.00 EUR 0.00 EUR
e) Date of the transaction 31.07.2020 UTC+1
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20200803025 ]

Directors' Dealings Archiv

2023

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen (pta025/03.08.2020/11:45) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Prof. Dr. Hermann Lübbert
2 Reason for the notification
a) Position/status Executive
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Another
Granting of 99,425 subscription rights in connection with the issue of a qualified subordinated mandatory convertible bond
c) Price(s) Volume(s)
0.00 EUR 0.00 EUR
d) Aggregated price Aggregated volume
0.00 EUR 0.00 EUR
e) Date of the transaction 31.07.2020 UTC+1
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20200803025 ]

2022

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen (pta025/03.08.2020/11:45) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Prof. Dr. Hermann Lübbert
2 Reason for the notification
a) Position/status Executive
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Another
Granting of 99,425 subscription rights in connection with the issue of a qualified subordinated mandatory convertible bond
c) Price(s) Volume(s)
0.00 EUR 0.00 EUR
d) Aggregated price Aggregated volume
0.00 EUR 0.00 EUR
e) Date of the transaction 31.07.2020 UTC+1
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20200803025 ]

2021

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen (pta025/03.08.2020/11:45) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Prof. Dr. Hermann Lübbert
2 Reason for the notification
a) Position/status Executive
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Another
Granting of 99,425 subscription rights in connection with the issue of a qualified subordinated mandatory convertible bond
c) Price(s) Volume(s)
0.00 EUR 0.00 EUR
d) Aggregated price Aggregated volume
0.00 EUR 0.00 EUR
e) Date of the transaction 31.07.2020 UTC+1
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20200803025 ]

Directors' dealings PDF-Archiv

2020 (Textmitteilungen)

PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR

Managers' transactions announcement according to article 19 MAR

Leverkusen (pta025/03.08.2020/11:45) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Prof. Dr. Hermann Lübbert
2 Reason for the notification
a) Position/status Executive
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Biofrontera AG
b) LEI 391200D6GFSVFGFQTL13
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0006046113
b) Nature of the transaction Another
Granting of 99,425 subscription rights in connection with the issue of a qualified subordinated mandatory convertible bond
c) Price(s) Volume(s)
0.00 EUR 0.00 EUR
d) Aggregated price Aggregated volume
0.00 EUR 0.00 EUR
e) Date of the transaction 31.07.2020 UTC+1
f) Place of the transaction Outside a trading venue

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: Nasdaq

[ source: http://www.pressetext.com/news/20200803025 ]